Quovadx Announces Final Court Approval of Class Action Settlement Agreement

  
    
  
  
    
      Quovadx, Inc. (Nasdaq:QVDX) today announced that on May 4, 2007, in 
      federal court in the District of Colorado, Senior District Judge Richard 
      P. Matsch granted final court approval of the settlement of the class 
      action lawsuit captioned Special Situations Fund III, L.P. et al. v. 
      Quovadx, Inc. This is the final resolution of the three legacy 
      shareholder lawsuits that arose from the Company’s 
      2004 restatement of historical financial results.
    
    
      This lawsuit was originally filed on May 17, 2004. Under the terms of 
      the approved settlement, class members and their counsel received $7.8 
      million in exchange for their release with prejudice of all claims that 
      were or could have been asserted against the Company and the former 
      individual defendants arising out of, or relating to, the acquisition of 
      Quovadx common stock in connection with Quovadx’s 
      December 2003 exchange offer for all of the outstanding shares of Rogue 
      Wave Software, Inc.
    
    
      About Quovadx, Inc.
    
    
      Quovadx (Nasdaq:QVDX) offers software and services for software system 
      development, extension, and integration to enterprise customers 
      worldwide. Quovadx has two divisions, including the Integration 
      Solutions division (ISD), which offers private and public healthcare and 
      healthcare IT organizations software infrastructure to facilitate system 
      interoperability and leverage existing technology, and, the Rogue Wave 
      Software division, which provides reusable software components and 
      services for enterprise-class application development and 
      high-performance SOA. A third business unit, CareScience, Inc., was sold 
      to Premier on March 30, 2007. For more information, please visit www.quovadx.com.
    
    
      QUOVADX, QUOVADX logo and ROGUE WAVE are registered trademarks or 
      service marks of Quovadx, Inc. in the U.S. and/or select foreign 
      countries. The absence of a trademark from this list does not constitute 
      a waiver of Quovadx Inc.’s intellectual 
      property rights concerning that trademark. All other company and 
      product names mentioned may be trademarks of the companies with which 
      they are associated.